Duolingo Inc vs Mesoblast Limited — how do they compare? Duolingo Inc trades at $134.6 (market cap $6.34B), while Mesoblast Limited trades at $16.68 (market cap $2.21B). The key difference: Duolingo Inc is far larger — about 2.9× Mesoblast Limited's market cap, and Mesoblast Limited is trading nearer its 52-week high, Duolingo Inc nearer its low. Which is the better fit depends on your goals.
| DUOL | MESO | |
|---|---|---|
Market Cap | $6.34B | $2.21B |
Sector | Technology | Technology |
52-Week High | $369.19 | $20.96 |
52-Week Low | $90.03 | $12.88 |
Enterprise Value | $5.11B | $2.21B |
Trailing returns across standard periods
Latest headlines on both assets
Duolingo Inc is a mobile learning platform to learn languages and the top-grossing app in the Education category on both Google Play and the Apple App Store. It has three predominant sources of revenue
Read more on DUOL →Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.
Read more on MESO →